Cost of 1st Line Treatment Failure in Braf V600 Mutated Metastatic Melanoma in France
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.2143
https://www.valueinhealthjournal.com/article/S1098-3015(16)33509-4/fulltext
Section Title :
Disease-Specific Studies
Section Order :
2026
First Page :
A720
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33509-4&doi=10.1016/j.jval.2016.09.2143